Tower Research Capital (TRC)’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.62K Sell
10,921
-11,045
-50% -$2.65K ﹤0.01% 4622
2025
Q1
$4.33K Buy
21,966
+2,436
+12% +$480 ﹤0.01% 4275
2024
Q4
$10.5K Buy
19,530
+14,865
+319% +$8.01K ﹤0.01% 3795
2024
Q3
$4.43K Buy
+4,665
New +$4.43K ﹤0.01% 4545
2024
Q1
Sell
-10,664
Closed -$8.46K 5829
2023
Q4
$8.46K Buy
10,664
+2,627
+33% +$2.08K ﹤0.01% 4509
2023
Q3
$6.27K Sell
8,037
-8,037
-50% -$6.27K ﹤0.01% 4626
2023
Q2
$14.9K Buy
16,074
+3,802
+31% +$3.52K ﹤0.01% 3642
2023
Q1
$13K Buy
12,272
+4,284
+54% +$4.54K ﹤0.01% 3944
2022
Q4
$12K Sell
7,988
-21,882
-73% -$32.9K ﹤0.01% 3668
2022
Q3
$32K Buy
29,870
+486
+2% +$521 ﹤0.01% 3534
2022
Q2
$50K Buy
29,384
+24,671
+523% +$42K ﹤0.01% 2869
2022
Q1
$10K Sell
4,713
-1,215
-20% -$2.58K ﹤0.01% 4267
2021
Q4
$22K Sell
5,928
-3,151
-35% -$11.7K ﹤0.01% 3543
2021
Q3
$47K Buy
9,079
+4,839
+114% +$25.1K ﹤0.01% 3008
2021
Q2
$18K Sell
4,240
-1,435
-25% -$6.09K ﹤0.01% 3976
2021
Q1
$30K Buy
5,675
+2,992
+112% +$15.8K ﹤0.01% 3556
2020
Q4
$14K Buy
+2,683
New +$14K ﹤0.01% 4080
2020
Q2
Sell
-9,591
Closed -$26K 4716
2020
Q1
$26K Buy
9,591
+9,429
+5,820% +$25.6K ﹤0.01% 1586
2019
Q4
$0 Sell
162
-21,310
-99% ﹤0.01% 3447
2019
Q3
$32K Buy
21,472
+21,372
+21,372% +$31.9K ﹤0.01% 2127
2019
Q2
$0 Sell
100
-6,290
-98% ﹤0.01% 3593
2019
Q1
$27K Buy
+6,390
New +$27K ﹤0.01% 2100
2018
Q4
Sell
-496
Closed -$7K 3777
2018
Q3
$7K Sell
496
-1,465
-75% -$20.7K ﹤0.01% 2940
2018
Q2
$23K Sell
1,961
-1,360
-41% -$16K ﹤0.01% 2342
2018
Q1
$37K Sell
3,321
-1,501
-31% -$16.7K ﹤0.01% 1840
2017
Q4
$32K Buy
+4,822
New +$32K ﹤0.01% 1677
2017
Q3
Sell
-3,663
Closed -$16K 3741
2017
Q2
$16K Buy
+3,663
New +$16K ﹤0.01% 1331
2017
Q1
Sell
-288
Closed -$1K 2982
2016
Q4
$1K Sell
288
-1,249
-81% -$4.34K ﹤0.01% 3555
2016
Q3
$11K Buy
1,537
+1,329
+639% +$9.51K ﹤0.01% 1988
2016
Q2
$2K Buy
+208
New +$2K ﹤0.01% 3851